Riggs Asset Managment Co. Inc. Viking Therapeutics, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $358 Million
- Q3 2024
A detailed history of Riggs Asset Managment Co. Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 10 shares of VKTX stock, worth $728. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$728
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
466Shares Held
65.9MCall Options Held
6.24MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$736 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$439 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$373 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$164 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$135 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.59B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...